Development of a conversation aid tool for patients with localized renal cell carcinoma at high risk of recurrence.

被引:0
|
作者
Stewart, Grant
Bargo, Danielle
Kilgariff, Sarah
Trennery, Claire
Bennett, Bryan
Battle, Dena
Casper, Jochen
Staehler, Michael D.
机构
[1] Univ Cambridge, Cambridge, England
[2] Pfizer Inc, New York, NY USA
[3] Adelphi Values, Cheshire, England
[4] KCCure, Alexandria, VA USA
[5] Klinikum Oldenburg, Oldenburg, Germany
[6] Univ Hosp Munich Grosshadern, Ludwig Maximilian Univ, Munich, Germany
关键词
D O I
10.1200/JCO.2018.36.6_suppl.608
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
608
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Fear of Cancer Recurrence in Patients With Localized Renal Cell Carcinoma
    Bergerot, Cristiane Decat
    Battle, Dena
    Philip, Errol J.
    Bergerot, Paulo Gustavo
    Msaouel, Pavlos
    Smith, Allan 'Ben'
    Bamgboje, Adeola Esther
    Shuch, Brian
    Derweesh, Ithaar H.
    Jonasch, Eric
    Stern, Adam P.
    Pal, Sumanta K.
    Staehler, Michael
    JCO ONCOLOGY PRACTICE, 2020, 16 (11) : 743 - +
  • [2] A multi-gene risk signature for improved identification of cutaneous squamous cell carcinoma (cSCC) patients with a high risk of recurrence.
    Schmults, Chrysalyne
    Arron, Sarah T.
    Wysong, Ashley
    Covington, Kyle R.
    Cook, Robert W.
    Newman, Jason
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [3] PARTIAL NEPHRECTOMY IS NOT ASSOCIATED WITH RECURRENCE IN SELECTED HIGH RISK RENAL CELL CARCINOMA PATIENTS
    Davidson, Emily L.
    Raman, Jay D.
    Master, Viraj A.
    Spiess, Philippe E.
    Dreyfuss, Leo D.
    Sexton, Wade J.
    Peyton, Charles C.
    Patil, Datta
    Shapiro, Daniel D.
    Allen, Glenn O.
    Abel, Jason
    JOURNAL OF UROLOGY, 2020, 203 : E256 - E256
  • [4] Risk of postoperative recurrence and prediction of drug response in localized clear cell renal cell carcinoma
    Ichiyanagi, Osamu
    Naito, Sei
    Ito, Hiromi
    Narisawa, Takafumi
    Yagi, Mayu
    Takai, Yuki
    Kanno, Hidenori
    Tsuchiya, Norihiko
    CANCER SCIENCE, 2024, 115 : 1409 - 1409
  • [5] Adjuvant Therapy for Localized High-Risk Renal Cell Carcinoma
    Wood, Erika
    Donin, Nicholas
    Shuch, Brian
    UROLOGIC CLINICS OF NORTH AMERICA, 2020, 47 (03) : 345 - +
  • [6] NATURAL HISTORY OF PATIENTS WITH DISEASE RECURRENCE AFTER NEPHRECTOMY FOR LOCALIZED RENAL CELL CARCINOMA
    Adamy, Ari
    Shariat, Shahrokh F.
    Chong, Kian Tai
    Russo, Grace
    Costaras, James
    Bernstein, Melanie
    Russo, Paul
    JOURNAL OF UROLOGY, 2011, 185 (04): : E799 - E799
  • [7] Fear of cancer recurrence among patients and survivors diagnosed with localized renal cell carcinoma
    Bergerot, Cristiane Decat
    Battle, Dena
    Philip, Errol James
    Bergerot, Paulo Gustavo
    Smith, Allan ' Ben'
    Rathmell, Kimryn
    Shuch, Brian M.
    Derweesh, Ithaar
    Jonasch, Eric
    Msaouel, Pavlos
    Pal, Sumanta K.
    Staehler, Michael D.
    Stern, Adam P.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [8] MACHINE LEARNING TO PREDICT RECURRENCE OF LOCALIZED RENAL CELL CARCINOMA
    Guo, Yanbo
    Braga, Luis
    Kapoor, Anil
    JOURNAL OF UROLOGY, 2019, 201 (04): : E145 - E145
  • [9] Is Adjuvant Immunotherapy Worth for All Patients with Clear-cell Renal Cell Carcinoma at High Risk of Recurrence?
    Marchioni, Michele
    Amparore, Daniel
    Marandino, Laura
    Bertolo, Riccardo
    Erdem, Selcuk
    Ingels, Alexandre
    Muselaers, Stijn
    Kara, Onder
    Pavan, Nicolo
    Roussel, Eduard
    Carbonara, Umberto
    Pecoraro, Angela
    Diana, Pietro
    Peccraro, Alessio
    Campi, Riccardo
    EUROPEAN UROLOGY OPEN SCIENCE, 2022, 46 : 39 - 42
  • [10] Is adjuvant immunotherapy worth for all patients with clear-cell renal cell carcinoma at high risk of recurrence?
    Campi, R.
    Amparore, D.
    Marandino, L.
    Bertolo, R.
    Erdem, S.
    Ingels, A.
    Muselaers, S.
    Pavan, N.
    Roussel, E.
    Carbonara, U.
    Pecoraro, A.
    Diana, P.
    Pecoraro, A.
    Marchioni, M.
    EUROPEAN UROLOGY, 2023, 83 : S676 - S677